Antihypertensive medications and cancer risk: Evidence from 0.27 million patients with newly diagnosed hypertension
BackgroundWhether specific antihypertensive treatments increase cancer risk in patients with hypertension is still controversial. We aimed to estimate the associations of different antihypertensive treatments with cancer risk in real-world settings.MethodsA longitudinal cohort study was designed in...
Saved in:
| Main Authors: | Huan Yu, Zhike Liu, Yiqun Wu, Liuyan Zheng, Kun Wang, Jingxian Wu, Huairong Wang, Kexin Ding, Ruotong Yang, Huziwei Zhou, Feng Sun, Yonghua Hu, Hongbo Lin, Peng Shen, Siyan Zhan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1559604/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of levothyroxine on major adverse cardiovascular events in patients with hypothyroidism and cardiovascular disease
by: Lijia Liu, et al.
Published: (2025-08-01) -
Development and validation of identification algorithms for five autoimmune diseases using electronic health records: a retrospective cohort study in China
by: Junting Yang, et al.
Published: (2025-04-01) -
Dissecting the bidirectional associations between the progression of gastrointestinal and endocrine diseases
by: Hongyan Liu, et al.
Published: (2025-05-01) -
Identification of shared genetic etiology of cardiovascular and cerebrovascular diseases through common cardiometabolic risk factors
by: Kexin Ding, et al.
Published: (2024-12-01) -
Current Status and Challenges of the Development on Rare Disease Multi-Security Mechanisms Driven by Data Intelligence in China
by: ZHAN Siyan, et al.
Published: (2025-01-01)